Session Details

[P1-06]Poster Session 1-06 Therapeutics of Gene

Thu. Oct 10, 2024 4:50 PM - 5:50 PM JST
Thu. Oct 10, 2024 7:50 AM - 8:50 AM UTC
Poster Room

[P1-06-1]Effect of M-Guard, an active myelin supplement, on anorexia and related apathy symptoms in adults with Down syndrome

Tatsuro Kondoh1, Kanako Morifuji2, Tadashi Matsumoto1 (1.Division of Developmental Disabilities, The Misakaenosno Mutsumi Developmental, Medical, and Welfare Center, Isahaya, Japan, 2.Department of Reproductive Health, Nagasaki University Graduate School of Biomedical Sciences HEALTH SCIENCES, Nagasaki, Japan)

[P1-06-2]An exploratory physician-initiated clinical trial of 5-ALA for ATR-X syndrome in Japan

Takahito Wada1,2, Kenji Kurosawa3,4, Nobuhiko Okamoto5, Takeshi Yoshida6, Koichiro Yoshiura7, Norifumi Shioda8 (1.Kyoto University Graduate School of Medicine, Kyoto, Japan, 2.Hidamari Clinic, Kawasaki, Japan, 3.Division of Medical Genetics, National Center for Child Health and Development, Tokyo, Japan, 4.Department of Medical Genetics, Kanagawa Children Medical Center, Yokohama, Japan, 5.Department of Medical Genetics, Osaka Women's and Children's Hospital, Izumi, Japan, 6.Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan, 7.Department of Human Genetics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 8.Department of Genomic Neurology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan)

[P1-06-3]A case of asymptomatic Wilson disease diagnosed with genetic testing based on the genetic information of the sibling

Hirotsugu Yanai1,2, Chika Satou2,3, Noriyo Yamashiki4, Tomoko Tamaoki5, Yuka Yotsumoto5, Saki Shimada2,3, Chie Hirai1, Manami Tada1, Kayoko Endo1, Yuichiro Kikawa1, Aya Yoshida2,3, Akio Kamiya2,3, Tran Nhat Van Nhu6, Hiroyasu Tsukaguchi2, Hidetaka Okada2,3, Masahiro Takada1 (1.Department of Breast Surgery, Hirakata Hospital, Kansai Medical University, Osaka, Japan, 2.Clinical Genetics Center, Hirakata Hospital, Kansai Medical University, 3.Department of Obstetrics and Gynecology, Hirakata Hospital, Kansai Medical University, 4.Department of Gastroenterology and Hepatology, Kansai Medical University Medical Center, 5.Center for Clinical and Molecular Genetics, Takatsuki General Hospital, 6.Department of Biomedical Sciences and Engineering, National Central University (NCU), Taiwan)

[P1-06-4]Efficacy and safety of selumetinib on plexiform neurofibroma in patients with neurofibromatosis type 1: mid-term results

Yoshihiro Nishida1, Norie Nonobe2, Hiroyuki Kidokoro2,3, Taichi Kato3, Kunihiro Ikuta4, Shiro Imagama4 (1.Department of Rehabilitation Medicine, Nagoya University Hospital, Nagoya, Japan, 2.Department of Ophthalmology, Nagoya University Graduate School of Medicine, 3.Department of Pediatrics, Nagoya University Graduate School of Medicine, 4.Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine)

[P1-06-5]Cochlear gene therapy for genetic hearing loss: a perspective on past, current and future studies

Hidekane Yoshimura, Yutaka Takumi (Department of Otorhinolaryngology - Head and Neck Surgery, Shinshu University School of Medicine)